| CVDs | Cardiovascular diseases |
| VSMCs | Vascular smooth muscle cells |
| SASP | Senescence-associated secretory phenotype |
| ALT | Alternative lengthening of telomeres |
| SA-β-Gal | Senescence-associated β-galactosidase |
| SIPS | Stress-induced premature senescence |
| ECs | Senescent endothelial cells |
| H2O2 | Hydrogen peroxide |
| OIS | Oncogene-induced senescence |
| ROS | Reactive oxygen species |
| OXPHOS | Oxidative phosphorylation |
| mTOR | Mechanistic target of rapamycin |
| SCAPs | Senescence-associated anti-apoptotic pathways |
| D+Q | Dasatinib and quercetin |
| HFrEF | Heart failure with reduced ejection fraction |
| AMPK | AMP-activated protein kinase |
| CAR | Chimeric antigen receptor |
| uPAR | Urokinase-type plasminogen activator receptor |
| IL-1 | Interleukin-1 |
| oxLDL | Oxidized low-density lipoprotein |
| Tregs | Regulatory T cells |
| CAR-Tregs | Chimeric antigen receptor regulatory T cells |
| HDAC | Histone deacetylase |
| DNMT | DNA methyltransferase |